20.02.2014 Views

IAG annual report—Concise

IAG annual report—Concise

IAG annual report—Concise

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

NOTES TO THE FINANCIAL STATEMENTS<br />

For the year ended 30 June 2005<br />

NOTE 11. EVENTS SUBSEQUENT TO REPORTING DATE (CONTINUED)<br />

(c) International financial reporting standards (continued)<br />

2b) Share based<br />

payments (continued)<br />

The <strong>IAG</strong> Group’s current practice is to acquire<br />

<strong>IAG</strong> shares on-market and hold them in trust to<br />

satisfy a future obligation for share based<br />

remuneration. The shares are purchased on or<br />

near grant date at the then market price. The<br />

cost of acquiring the shares is initially recorded<br />

as a prepayment and is then expensed in full,<br />

generally over the period during which the<br />

employees provide related services.<br />

Under A-IFRS the fair value at grant date of<br />

share based remuneration is required to be<br />

recognised as an expense over the period from<br />

grant date until the equity instruments vest<br />

fully to the employee. For equity settled share<br />

based payments, an equity reserve is created<br />

as the expense is recognised. At each<br />

reporting date the total accumulated expense<br />

will be adjusted through the statement of<br />

financial performance based on the latest<br />

estimate of the number of equity instruments<br />

that will vest, considering only employee<br />

turnover, and taking into account the expired<br />

portion of the vesting period.<br />

The vesting conditions for the two plans are<br />

different with only the PARs Plan incorporating<br />

a market based vesting condition. If equity<br />

instruments in either of the plans do not vest<br />

because the participant ceases to be employed<br />

by the <strong>IAG</strong> Group then the expense charged in<br />

relation to that participant will be reversed. If<br />

equity instruments in the PARs Plan do not<br />

vest only because the market condition is not<br />

met, then the expense will not be reversed.<br />

The A-IFRS requirement to expense the fair<br />

value of the equity instruments granted may be<br />

different to the fair value (on-market purchase<br />

price) of acquiring the relevant number of<br />

shares to support the arrangements. For the<br />

PARs Plan, the fair value of the rights granted<br />

is lower than the market value of the shares<br />

purchased on or near grant date because of<br />

the variables and uncertainty that influence<br />

whether the participant will ever receive the<br />

share and what the value of the share will be<br />

at that time. For the NED Plan, the on-market<br />

share price at grant date is used as the fair<br />

value of the equity instrument granted because<br />

the shares vest on a pro-rata daily basis with<br />

limited forfeiture conditions and the participant<br />

is entitled to dividends and other shareholder<br />

rights during the vesting period.<br />

The requirement to determine the fair value of<br />

the share based remuneration and recognise<br />

this expense over the period from grant date to<br />

vesting date will result in an initial reduction in<br />

the expense recognised for the <strong>IAG</strong> Group, to<br />

that currently recorded in relation to share<br />

based payments.<br />

Equity remuneration<br />

trusts to be<br />

consolidated<br />

3) Non-goodwill<br />

intangibles<br />

All current non-goodwill<br />

intangible assets<br />

qualify for recognition<br />

Introduction of new<br />

software development<br />

asset<br />

A transitional adjustment for the <strong>IAG</strong> Group<br />

will be made to retained profits as at 1 July<br />

2004 of $2 million representing the<br />

accumulated reduction in the expense up to<br />

that date. An additional adjustment for the<br />

<strong>IAG</strong> Group will be made to retained profits as<br />

at 1 July 2005 of $5 million representing the<br />

accumulated reduction in the expense up to<br />

that date. The expense will be matched by a<br />

credit to an equity reserve. It is noted that<br />

certain matters in relation to share based<br />

payments are still subject to changing<br />

interpretation, which may impact on the<br />

determination of these adjustments.<br />

Under A-IFRS the equity remuneration trusts<br />

used to manage the share based<br />

arrangements will be consolidated by the <strong>IAG</strong><br />

Group. Two trusts will be consolidated directly<br />

by the parent entity while one trust will be<br />

consolidated directly by a subsidiary. The<br />

parent and the <strong>IAG</strong> Group will recognise the <strong>IAG</strong><br />

shares, the major asset of the trusts, as<br />

negative equity (referred to as treasury shares).<br />

The treasury shares will be measured at cost<br />

(total amount paid to acquire the shares), and<br />

will be shown as a deduction from equity. The<br />

shares held by the trusts as at 30 June 2004<br />

that are to be consolidated, were acquired on<br />

different dates at a total cost of $20 million for<br />

the parent and $21 million for the <strong>IAG</strong> Group.<br />

The shares held by the trusts as at 30 June<br />

2005 that are to be consolidated, were<br />

acquired on different dates at a total cost of<br />

$33 million for the parent and $34 million for<br />

the <strong>IAG</strong> Group. When the relevant rights are<br />

exercised, the Group will effectively reissue the<br />

shares, which will be recognised as equity<br />

measured at the net expense incurred in<br />

providing the shares.<br />

Existing non-goodwill intangible assets on the<br />

<strong>IAG</strong> Group’s statement of financial position<br />

at 1 July 2004 and 30 June 2005 meet the<br />

recognition and measurement requirements<br />

of A-IFRS and so the accounting treatment,<br />

including amortisation, will remain unchanged.<br />

They will be subject to impairment testing.<br />

There are no impairment charges for these<br />

assets at 1 July 2004, 31 December 2004,<br />

or 30 June 2005.<br />

In certain circumstances under A-IFRS,<br />

development phase expenditure will be<br />

capitalised and so recognised as an internally<br />

generated intangible asset. Software<br />

development is the only development<br />

expenditure for the <strong>IAG</strong> Group. The <strong>IAG</strong> Group<br />

is not currently carrying any capitalised<br />

software development costs in the statement<br />

of financial position but will recognise such<br />

an asset under the more prescriptive A-IFRS<br />

requirements. Only software development<br />

projects with total budgeted expenditure of<br />

more than $2 million will be capitalised. All<br />

other software related costs are treated as<br />

maintenance expenditure, being an overall part<br />

of maintaining an efficient operating<br />

environment, and are expensed as incurred.<br />

72 <strong>IAG</strong> Annual Report 2005

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!